Effectiveness of Interactive Exergame in Older Adults With Sarcopenia
NCT ID: NCT04770558
Last Updated: 2021-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2021-03-09
2022-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Exercise With a Towel in Elderly With Sarcopenia
NCT03258827
The Effect of Tai Chi Exercise Among Elders With Sarcopenia
NCT05145036
Effect of Technology-assisted Physical Therapy for Patient With High Risk of Sarcopenia
NCT05687630
VR-based Rehabilitation in the Treatment and Prevention of Sarcopenia of Older Residents
NCT03809104
Maximizing Mechanisms of Muscle Hypertrophy to Combat Sarcopenia in Older Adults
NCT02442479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exergame group
The exergame group will receive exergame training for 12 weeks, 2 times a week and 60 min per session.
Interactive Exergame
The one-to-one supervised training session consists of 10 min warm-up exercise, 40 min interactive exergame, and 10 min cool-down exercise. Both physical (muscle strength, coordination and balance in lower limbs) and cognitive functions (visuospatial, attention, short-term memory, calculation, reaction and executive function) will be trained through the interactive exergame.
Control group
The control group will not receive any intervention and maintain their lifestyle for 12 weeks.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interactive Exergame
The one-to-one supervised training session consists of 10 min warm-up exercise, 40 min interactive exergame, and 10 min cool-down exercise. Both physical (muscle strength, coordination and balance in lower limbs) and cognitive functions (visuospatial, attention, short-term memory, calculation, reaction and executive function) will be trained through the interactive exergame.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. able to walk 6 meters without assistance devices
3. older adults with possible sarcopenia, sarcopenia or severe sarcopenia
Exclusion Criteria
2. people with built-in electronic medical equipment
3. people with central nervous system disease such as stroke or Parkinson's disease
4. score in ascertain dementia 8 more than 2
5. people with mental illness
65 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shu-Chun Lee
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shu-Chun Lee, PhD
Role: PRINCIPAL_INVESTIGATOR
School of Gerontology Health Management
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Community daycare center
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shu-Chun Lee, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N202012029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.